Carregant...
IMMU-04. OVERCOMING IMMUNE EVASION IN GLIOBLASTOMA
The negative phase 3 trial of anti-PD-1 in human glioblastoma (GBM) contradicts preclinical data showing eradication of GL261 mouse brain tumors by checkpoint inhibitors (CPI). To understand whether the tumor microenvironment contributed to this discrepancy, we immunoprofiled 19 human GBM tumors by...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217332/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.507 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|